Citadel Advisors »

Cyclacel Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Cyclacel Pharmaceuticals (BGMS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Cyclacel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cyclacel Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclacel Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $22k 22k 1.00

More positions owned by Citadel Advisors

State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Spdr Gold Tr Gold Shs Call Option (GLD)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
Micron Technology Call Option (MU)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Netflix Call Option (NFLX)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl C Call Option (GOOG)

View all positions for Citadel Advisors

Top funds holding Cyclacel Pharmaceuticals

Renaissance Technologies
Citadel Advisors
Geode Capital Management
Tower Research Capital
UBS Group
SBI Securities
Archer Investment Corp
Advisor Group Holdings

View all funds holding Cyclacel Pharmaceuticals